# Safety of Nerivio in Pregnant Women With Migraine

> **NCT05464069** · — · COMPLETED · sponsor: **Theranica** · enrollment: 145 (actual)

## Conditions studied

- Migraine
- Pregnancy Related

## Interventions

- **DEVICE:** Nerivio
- **DRUG:** Migraine Relief

## Key facts

- **NCT ID:** NCT05464069
- **Lead sponsor:** Theranica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2022-11-28
- **Final completion:** 2022-12-07
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05464069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05464069, "Safety of Nerivio in Pregnant Women With Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05464069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*